about
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.The Psychiatric Impact of HIV.Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs.Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and DogsEnhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based ProdrugsInvestigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial AgonistsStructure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic StabilityGlutamine blockade induces divergent metabolic programs to overcome tumor immune evasionLooking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the BrainA novel and potent brain penetrant inhibitor of extracellular vesicle releaseTumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine ProdrugsThe Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective AgonistsDiscovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists
P50
Q40113255-AFE7EA24-FCE5-4B3F-B022-7E2E0D213033Q40201160-B0E0943B-2508-47DC-AAF6-4F88E4C806EEQ46418121-39456555-0A54-4AB3-8F42-D4448D2B8BACQ47906548-2EA62496-232E-4B37-9A52-B0A23F0AD2EEQ48141734-5E444C9A-5E2A-4269-AE41-22CEFFE0056AQ48171011-ABE4A4B2-21A2-4215-A2F2-F50ABB53223EQ48320010-4E502F22-C275-4217-B839-3179F1F26119Q88340988-E322C916-80EB-421B-96D7-DBDEA4E8F0B7Q90020314-5DAC68FF-F21B-4E6A-92B4-196EEEB5A824Q90126904-412B2177-3DB9-404B-8984-2E5E6B685AF2Q90985300-9762510D-1900-4940-88A5-3654D84B28E9Q91172864-43C6FD88-ED81-4B38-A1D8-3BFE0543C008Q91364094-6A96E22A-3D65-4486-91E3-279E4A8ABADDQ91625949-61F439DC-ABE5-4B05-85A3-15161C1C0DA0Q92496523-77677B51-D3D2-4B9A-A02B-1976025341E2Q93143050-0DEC5751-0405-44D3-AB2D-CF579DBF55D0Q93195301-6C4B02B8-A1EE-4977-B866-772CEC077989
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Barbara S Slusher
@ast
Barbara S Slusher
@en
Barbara S Slusher
@es
Barbara S Slusher
@nl
type
label
Barbara S Slusher
@ast
Barbara S Slusher
@en
Barbara S Slusher
@es
Barbara S Slusher
@nl
prefLabel
Barbara S Slusher
@ast
Barbara S Slusher
@en
Barbara S Slusher
@es
Barbara S Slusher
@nl
P106
P21
P31
P496
0000-0001-9814-4157